Kaleido Biosciences, Inc.
Kaleido Biosciences, Inc. (KLDO) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001751299 · KLDO · OTC · as of Jun 8, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001751299 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Kaleido Biosciences, Inc. (OTC: KLDO) has submitted 203 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2019. As a Healthcare sector company with CIK 0001751299, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Kaleido Biosciences, Inc.'s most comprehensive regulatory disclosure. The most recent Kaleido Biosciences, Inc. 10-K was filed on 2022-04-01 for fiscal year ending 2022. Historical KLDO 10-K annual reports are available from 2018 through 2022.
Investors researching Kaleido Biosciences, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
KLDO SEC Filings · 8 questionsKaleido Biosciences, Inc. (KLDO) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 203 filings and access original documents at no cost. Kaleido Biosciences, Inc.'s CIK is 0001751299.